Immunology Report â€“ DSA screen and donor-derived cfDNA (AlloSure)

Date: 10/4/2023

Results:
- Donor-Specific Antibodies: Negative
- HLA class I: None detected
- HLA class II: None detected
- Donor-derived cfDNA (AlloSure): 0.24% (normal <1%)

Interpretation: No evidence of active rejection. Continue current immunosuppression regimen.
